Metraipolis › archive › dc_f2ca7542f731
Immune Checkpoint Inhibitor-induced Hepatitis, an Emerging Issue in Precision Cancer Therapy Era: A Narrative Literature Review — Europe PMC PMID:41605828
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41605828
- DOI
- 10.5041/rmmj.10571
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T11:36:21.399Z
- SHA-256 of the archived text
20f1427c288e9cb037eced4cc0f49e773699d5141c0cd6fd05e99c95f4fc1131- Stable URL of this page
https://metraipolis.com/documento/dc_f2ca7542f731
How to cite
Immune Checkpoint Inhibitor-induced Hepatitis, an Emerging Issue in Precision Cancer Therapy Era: A Narrative Literature Review — Europe PMC PMID:41605828 — Europe PMC (en), https://europepmc.org/article/MED/41605828 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f2ca7542f731 (Metraipolis archive dc_f2ca7542f731, sha256 20f1427c288e9cb037eced4cc0f49e773699d5141c0cd6fd05e99c95f4fc1131)
BibTeX
@misc{dcf2ca7542f731,
title = {Immune Checkpoint Inhibitor-induced Hepatitis, an Emerging Issue in Precision Cancer Therapy Era: A Narrative Literature Review — Europe PMC PMID:41605828},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41605828},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f2ca7542f731; sha256 20f1427c288e9cb037eced4cc0f49e773699d5141c0cd6fd05e99c95f4fc1131},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41605828. Agents can read the archived copy with the MCP tool read_document.